Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Stanford University

Jan 2007
Stanford University of Palo Alto, Calif., and the Berlin-based Schering AG of the Bayer Group of Leverkusen, Germany, have entered into a joint research program to identify PET tracers for tumor imaging. Schering will have the option to assume exclusive rights to develop and commercialize such tracers, which could enable early detection of pathological changes in the body.

BiophotonicsNews & Featurespathological changesPET tracersStanford University

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!